55196-46-8

Basic information

• Product Name: 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)- amino]-4,6-dimethyl-9-oxo-3-â-Dribofuranosyl-,methyl ester,(RS)-
• Synonyms: (αS)-α-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-β-D-ribofuranosyl-4,9-dihydro-3H-imidazo[1,2-α]purine-7-butanoic acid methyl ester;(αS)-α-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-β-D-ribofuranosyl-4,9-dihydro-3H-imidazo[1,2-a]purine-7-butanoic acid methyl ester;(S)-4-[3-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-4,6-dimethyl-9-oxo-4,9-dihydro-3H-imidazo[1,2-a]purin-7-yl]-2-methoxycarbonylamino-butyric acid methyl ester;(S)-4-<α-<(methoxycarbonyl)amino>-4,6-dimethyl-9-oxo-3-(β-D-ribofuranosyl)-4,9-dihydro-3H-imidazo<1,2-a>purin-7-yl>butanoic acid methyl ester;yW
• CAS NO: 55196-46-8
• Molecular Formula: C21H28N6O9
• Molecular Weight: 508.48200
• Mol File: 55196-46-8.mol
• Article Data: 0

Chemical Properties

• Density: 1.68±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)- amino]-4,6-dimethyl-9-oxo-3-â-Dribofuranosyl-,methyl ester,(RS)- (CAS DataBase Reference)
• NIST Chemistry Reference: 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)- amino]-4,6-dimethyl-9-oxo-3-â-Dribofuranosyl-,methyl ester,(RS)- (55196-46-8)
• EPA Substance Registry System: 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)- amino]-4,6-dimethyl-9-oxo-3-â-Dribofuranosyl-,methyl ester,(RS)- (55196-46-8)

Safety Data

• Hazardous Substances Data: 55196-46-8(Hazardous Substances Data)

Usage

Description

3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)-amino]-4,6-dimethyl-9-oxo-3-á-Dribofuranosyl-,methyl ester,(RS)is a complex organic compound with a unique molecular structure. It belongs to the family of tricyclic ribonucleosides and is characterized by its imidazo[1,2-a]purine core, which is linked to a butanoic acid chain. The molecule also features a methoxycarbonyl-amino group, a 4,6-dimethyl substitution pattern, and a 9-oxo functional group. The presence of a Dribofuranosyl moiety and a methyl ester group further contribute to its distinct chemical properties.

Uses

Used in Pharmaceutical Industry:
3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)-amino]-4,6-dimethyl-9-oxo-3-á-Dribofuranosyl-,methyl ester,(RS)is used as a potential therapeutic agent for the treatment of various human diseases. Its unique molecular structure allows it to interact with specific biological targets, such as enzymes and receptors, which are involved in the pathogenesis of these diseases. 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-â-Dribofuranosyl-,methyl ester,(RS)'s ability to modulate these targets can lead to the development of novel treatments for conditions like cancer, neurological disorders, and inflammatory diseases.
Used in Research and Development:
In the field of research, 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)-amino]-4,6-dimethyl-9-oxo-3-á-Dribofuranosyl-,methyl ester,(RS)serves as an important tool for studying the structure-activity relationships of various biologically active molecules. Its unique chemical properties make it a valuable probe for investigating the mechanisms of action of different enzymes and receptors, as well as for identifying new potential drug targets.
Used in Drug Delivery Systems:
Similar to gallotannin, 3H-Imidazo[1,2-a]purine-7-butanoic acid,4,9-dihydro-R-[(methoxycarbonyl)-amino]-4,6-dimethyl-9-oxo-3-á-Dribofuranosyl-,methyl ester,(RS)can also be incorporated into novel drug delivery systems to enhance its bioavailability and therapeutic efficacy. By employing various organic and metallic nanoparticles as carriers, the compound can be effectively delivered to target cells, improving its overall performance in treating specific diseases.

Downstream Products

• 35693-91-5 wybutine